Atlas to Demonstrate Infection Control Solution at APIC 2011 Annual Conference

CALABASAS, Calif.--(BUSINESS WIRE)-- Atlas Public Health today announced plans to participate in APIC’s 38th Annual Educational Conference and International Meeting to be held June 27-29 in Baltimore, MD at the Baltimore Convention Center. This year’s theme is “Translating Science—Sustainable Solutions.”

The Company will demonstrate ATLAS Guardian™ Infection Control, a software application uniquely designed to address the combined objectives of surveillance and control, facility-wide analysis, and regulatory reporting of infectious disease and [other] HAI incidents occurring within the hospital enterprise. Guardian reduces manual entry and facilitates rapid recognition and actionable analysis of infections, as well as statutorily-mandated reporting to NHSN and state public health officials. Guardian is a flexible epidemiological solution comprehensive enough to address the needs of virtually any Infection Control program, enabling Infection Control (IC) units to respond to infections rapidly and effectively. Atlas offers a proven solution for aggregating data from disparate hospital systems and facilitating a hospital-wide dashboard view of all HAI events allowing the ICP to spend more time minimizing HAI events and less time performing data entry. During this year’s conference, the Company will also demonstrate the mobile version of ATLAS Guardian IC that allows the ICP to review isolation patients and access patient records following receipt of email alerts from a tablet device such as the Apple iPad®.

“Having effective systems in place to identify, investigate, and respond to infections is a critical component of any IC program,” states Mark Marostica, Atlas Public Health Vice President of Sales and Marketing. “Guardian provides real-time information. By isolating the infection source, hospitals can proactively reduce risks, protect their patients, decrease non-reimbursements, and meet their mandated reporting requirements,” continues Marostica. “Moreover, the analytical reports and graphs generated in Guardian provide strong measurement tools to assess the effectiveness of IC protocols and in the long run can prevent future infections.”

Participants of the conference can learn how ATLAS Guardian can support and enhance public health practices by visiting Booth #1143 in the Baltimore Convention Center.

According to their website, APIC’s Annual Educational Conference & International Meeting is the largest annual gathering of infection preventionists in the world. It is considered the premier educational opportunity for healthcare professionals in all settings who have infection prevention responsibilities. It is the meeting place for infection preventionists of all levels of experience and those in related fields to expand their knowledge bases, establish practical expertise in infection prevention and epidemiology, and network with experts and peers.

About Atlas Public Health

Atlas Public Health provides a state-of-the-art web-based communicable disease tracking, reporting, and case management system. By reducing manual entry and facilitating standards based communication between healthcare providers and public health officials, Atlas enables agencies to respond to potential threats to the public health rapidly and effectively. For more information, visit us at www.AtlasPublicHealth.com.

iPad is a registered trademark of Apple Inc.



CONTACT:

Atlas Public Health
Director of Marketing
818.224.6229

KEYWORDS:   United States  North America  California  Maryland

INDUSTRY KEYWORDS:   Technology  Data Management  Internet  Software  Health  Hospitals  Other Health  General Health

MEDIA:

Logo
 Logo

Suggested Articles

The profit margins and management of Community Health Group raise questions about oversight of managed care insurers.

Financial experts are warning practices about the pitfalls of promoting medical credit cards to their patients.

A proposed rule issued by HHS on Tuesday would expand short-term coverage, a move Seema Verma said will have "virtually no impact" on ACA premiums.